Cagdas Yilmaz has been appointed the Europe Middle East and Africa (EMEA) Integrated Brand Value Team Leader of Johnson&Johnson’s pharmaceutical company, Janssen Turkey. Prior to his new position, Yilmaz worked as Oncology and Hematology Business Unit Director for the company. In his new position, Yilmaz will be responsible for the implementation and management of commercial strategies and tactics for the EMEA region for cell therapies. Cagdas Yilmaz, who will also lead the Integrated Brand Value Team, will guide launch preparations across functions and EMEA in the new period. Yilmaz, who has 20 years of professional experience, has worked in different positions since 2013 at Johnson&Johnson.
Latest News:
Arzum eyes to become a global brand
TÜV Austria to invest EUR 20m in Turkey
InDrive eyes new cities in Turkey
It is the old balance of payments, let’s see the new one!
Base equalization policy
The fine print of the PPK summary
Akkuyu NPP to contribute Turkey’s GDP with USD 50bn
Turks’ investment migration enquiries to hit a record in 2023
Turkish mission in Shusha, recognition of TRNC and Libya
KKM may create TRY 150bn currency burden on the public in June
Simsek and Erkan to set right this outlook!
Loris Parfum eyes to grow by 30% this year
The new government, a new policy
U.S. Consulate General in Istanbul Celebrates 247 Years of U.S. Independence
Government has a chance in addition to challenges!
Currency shock puts at least TRY 300bn additional KKM burden on public
Will foreign policy knots be untied?
The election is over; what will come up next?
TOBB makes its A-Team
Turkey at a Glance
YILMAZ BECOMES EMEA INTEGRATED BRAND VALUE TEAM LEADER OF JANSSEN TURKEY
August 9, 2021August 2, 2021

Leave a Reply